EU Clinical Trials Register
|
|
- Dana Bradley
- 8 years ago
- Views:
Transcription
1 EU Clinical Trials Register Sponsor Contact Information Abbott Laboratories Ltd Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE UK Telephone number Ablynx NV Ablynx NV Technologiepark 21 B-9052 Zwijnaarde Belgium Telephone number clinicaltrials@ablynx.com Actelion Pharmaceuticals Ltd (Global Medical Information) Actelion Pharmaceuticals Ltd. Gewerbestrasse 3 CH-4123 Allschwil medinfo@actelion.com Active Biotech AB PO Box 724, Scheelevägen 22, SE Lund, Sweden Telephone Number clinicaltrials@activebiotech.com Amgen Medical Information Amgen (EUROPE) GmbH Dammstrasse 23 P.O. Box 1557 (not on the website) (CH-)6300 Zug MedinfoInternational@amgen.com Astellas Global Development Operations Elisabethhof EW Leiderdorp Telephone Number contact@nl.astellas.com Page - 1
2 AstraZeneca AB Austrian Breast & Colorectal Cancer Study Group (ABCSG) Nussdorfer Platz 8 / , A-1190 Wien Telephone number Fax number info@abcsg.at Bayer HealthCare AG Bayer Clinical Trials Contact CTP Team / Ref: "EU CTR" Bayer Pharma AG, S102, Level 2, Room Berlin Contact phone number: clinical-trials-contact@bayerhealthcare.com BIAL Portela & Cª, SA Section of Clinical Research and Drug Safety Management À Avenida da Siderurgia Nacional S. Mamede do Coronado Portugal Telephone Number info@bial.com BioAlliance Pharma 49 boulevard du Général Martial Valin Paris, France Telephone number Clinicaltrials@bioalliancepharma.com Biogen Idec Ltd Innovation House, 70 Norden Road Maidenhead, Berkshire, UK. SL6 4AY clinicaltrials@biogenidec.com Boehringer Ingelheim Boehringer Ingelheim Pharma GmbH & Co. KG QRPE Processes and Systems Coordination Clinical Trial Information Disclosure Binger Strasee Ingelheim am Rhein Telephone number clintriage.rdg@boehringer-ingelheim.com
3 Bristol-Myers Squibb International Corporation BMS- EU StartUp Department Attn: Dept Manager Parc de l'alliance, Avenue de Finlande, Braine l'alleud Belgium Celgene Corporation Corporate Woods Bldg. 70, Suite W. 109th Street Overland Park, Kansas U.S.A. International toll-free telephone number EISAI European Medical Information Eisai Europe Limited European Knowledge Centre, Mosquito Way Hatfield Herts AL10 9SN Telephone number Telephone number Fax number Eli Lilly and Company Eli Lilly and Company Limited Lilly S.A. EORTC European Organisation for Research and Treatment of Cancer AISBL-IVZW Avenue E. Mounierlaan, 83/11 Bruxelles 1200 Brussel Belgique - Belgïe Telephone Number +32 (0) eortc@eortc.be ERYtech Pharma Batiment Adénine 60 Avenue Rockefeller LYON - FRANCE Telephone Number vsemareg@erytech.com
4 Genmab A/S Bredgade 34, 1260 Copenhagen K, Denmark Telephone Number Genzyme Europe BV Gooimeer 10, 1411 DD Naarden, The Netherlands GlaxoSmithKline GlaxoSmithKline, Iron Bridge Road, Stockley Park West, Uxbridge, Middlesex, UB11 1BU, UK Telephone number I.R.I.S Institut de Recherches Internationales Servier International and Pre-Submission Division, Clinical Studies Department 6, place des Pleiades Courbevoie Cedex France Telephone number clinicaltrials@servier.com MedImmune Limited One MedImmune Way Gaithersburg, MD Telephone number clinicaltrialenquiries@medimmune.com Menarini Ricerche S.p.A. Via Sette Santi, Florence, (FI) Italy Telephone number Clinicaltrials@menarini.com Merck KGaA or Merck Serono S.A. Geneva Merck Merck KGaA Frankfurter Strasse Darmstadt Telephone number service@merckgroup.com
5 Merck Sharp and Dohme Corp 126 E. Lincoln Avenue RY34-A100 Rahway, NJ USA Telephone number Merz Pharmaceuticals GmbH Global Clinical Development Operations Eckenheimer Landstrasse Frankfurt Norpharma A/S Medical Manager Slotsmarken 15, DK-2970 Hoersholm, Denmark Telephone number Novartis Pharma AG Forum 1, Novartis Campus 4056 Basel, Telephone number Novo Nordisk A/S Global Clinical Registry (GCR,1452) Vandtaarnsvej 114, VTB DK-2860 Soeborg Denmark Orion Corporation Tengstöminkatu 8, P.O.Box 425; FI Turku Finland Telephone number Pfizer Inc 235 E 42 nd Street New York NY10017, USA Telephone Number Fax Number ClinicalTrials.govCallCentre@pfizer.com
6 PharmaMar Avda. De los Reyes 1 Pol. Ind. La Mina Colmenar Viejo (Madrid) Spain Telephone number clinicaltrials@pharmamar.com Phytopharm plc Lakeview House 2 Lakeview Court Ermine Business Park Huntingdon PE29 6UA Telephone number medical@phytopharm.com F. Hoffmann-La Roche Ltd. Trial Information Support Line-TISL Grenzacherstrasse , Basel global.rochegenentechtrials@roche.com Genentech Inc. C/O F. Hoffmann-La Roche Ltd. Trial Information Support Line-TISL Grenzacherstrasse , Basel global.rochegenentechtrials@roche.com Sanofi-aventis Trial Transparency Team (CSO-SCP - Clinical Documentation) Telephone Number (BWX/USA) Contact-us@sanofi-aventis.com TiGenix n.v. Romeinse Straat 12/2, B-3001 Leuven, Belgium Telephone Number clinicaltrialenquiries@tigenix.com Vectura Group Plc 1 Prospect West Chippenham SN14 6FH Telephone Number clinicaltrialsenquiries@vectura.com
7 Vifor Pharma Ltd Global Medical Information Flughofstr. 61 P.O. Box CH-8152 Glattbrugg Telephone number Fax number
Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
More informationPharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
More informationSmall-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
More informationPharma working capital leaves room for improvement
October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.
More informationCODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association
More informationRx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
More informationClinical trial research agreement Agreed schedule 4 or 7 clause amendments
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for
More informationKEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
More informationM&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends
M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends Symposium Life Science am Kapitalmarkt Frankfurt, 3. Juni 28 Global biotech industry Strong growth in most areas but Visible product
More informationCHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
More informationMalignant Mesothelioma - Pipeline Review, H1 2015
Brochure More information from http://www.researchandmarkets.com/reports/3308784/ Malignant Mesothelioma - Pipeline Review, H1 2015 Description: Malignant Mesothelioma - Pipeline Review, H1 2015 Summary
More informationMetastatic Breast Cancer - Pipeline Review, Q1 2011
Brochure More information from http://www.researchandmarkets.com/reports/1524592/ Metastatic Breast Cancer - Pipeline Review, Q1 2011 Description: Metastatic Breast Cancer - Pipeline Review, Q1 2011 Summary
More informationDecision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors
More informationGlobal Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
More informationehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
More informationIn the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
More informationPertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer
Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians and basic scientists
More informationThe World's Top 100 Pharmaceutical Companies
Brochure More information from http://www.researchandmarkets.com/reports/1878687/ The World's Top 100 Pharmaceutical Companies Description: Did you know? - Dr. Jeremy Levin is Senior Vice President, Strategy,
More informationOracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
More informationGlobal Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
More informationVAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY
VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY SUMMARY Healthcare Summary Personal health care expenditures projected to grow 26% in the next 4 years Hospital care sector comprises
More informationThe United States False Claims Act Qui Tam Whistleblower Law
The United States False Claims Act Qui Tam Whistleblower Law Getnick & Getnick LLP Counsellors At Law Rockefeller Center, 620 Fifth Avenue New York, NY 10020 Phone: (212) 376-5666 Fax: (212) 292 3942 www.getnicklaw.com
More informationThe Importance of the Pharmaceutical Industry for Switzerland
Study on behalf of Interpharma The Importance of the Pharmaceutical Industry for Switzerland BAK Basel Economics Michael Grass, Samuel Mösle In collaboration with Polynomics Published by: Interpharma,
More informationThe Pharmaceutical Industry in Figures
The Pharmaceutical Industry in Figures Key Data 2014 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the researchbased pharmaceutical
More informationC h a r t 1 - KPNQwest Group
C h a r t 1 - Group NV BIJLAGE / ANNEX 1 IP Services BV Services Finance BV financing moratorium: 30-05 bankruptcy: 25-09 09-2002 Assets Central Europe BV moratorium: 18-06 moratorium has ended Netherlands
More informationPivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform
PRESS RELEASE Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform Pivot Park Screening Centre in Oss will play an important role in a new pan-european drug
More informationStakeholder Perspectives: Mild Cognitive Impairment and Dementia
A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?
More informationThe Pharmaceutical Industry in Figures
The Pharmaceutical Industry in Figures Key Data 2015 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the researchbased pharmaceutical
More informationRelapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015
Brochure More information from http://www.researchandmarkets.com/reports/3293079/ Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015 Description: Relapsing Remitting Multiple Sclerosis
More informationDRUGS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS: GLOBAL MARKETS
DRUGS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS: GLOBAL MARKETS PHM159A March 2014 Sanjukta Bhattacharyya Project Analyst ISBN: 1-56965-754-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationThe Role Of Industry in the Australian Clinical Trials Sector
Mitch Kirkman, Development QA Manager Australian Clinical Trials Alliance Symposium 09 October 2015 CORP0270 September 2015 Global Clinical Development Local Clinical Trials Australian Medical Research
More informationMalignant Pleural Mesothelioma - Pipeline Review, H2 2014
Brochure More information from http://www.researchandmarkets.com/reports/2904677/ Malignant Pleural Mesothelioma - Pipeline Review, H2 2014 Description: Malignant Pleural Mesothelioma - Pipeline Review,
More informationOFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013
Introduction OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 In 2007, Attorney General Wasden filed lawsuits against 33 pharmaceutical companies for
More informationTotal Compensation Measurement. Global TCM Participants. Turkey
Total Compensation Measurement 2008 Global TCM Participants Turkey Turkey 2008 TCM Participants Summary Information The table below lists key summary information on the 67 TCM participants for 2008. Measure
More informationA survey conducted by: The Swedish Drug Development Pipeline May 2011
A survey conducted by: The Swedish Drug Development Pipeline May 2011 The survey In February March 2011 a survey of the Swedish Drug Development Pipeline was conducted by SwedenBIO in cooperation with
More informationMultiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine
More informationPharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a
More information6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
More informationCommercial Insight Osteoarthritis and Rheumatoid Arthritis
A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and
More informationPharmaceutical Marketing Disclosures
Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,
More informationLife Sciences Financing Summary Europe December 2014
Europe December 2014 In stark contrast to their summer inactivity, private Biotech European companies (Therapeutics & Diagnostics) raised the highest equity financing amount of the year in September with
More informationManufacturer of drug substance
Original s and Biosimilars (marketing authorizations in the EU) Date: January 2016 1) Somatropin s ORIGINAL PRODUCTS: Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli Humatrope Somatropin
More informationVEDLEGG I. Liste Over Navn, Legemiddelformer, Legemiddelstyrker, Administrasjonsmåte, Innehavere Av Markedsføringstillatelsen I Medlemslandene
VEDLEGG I Liste Over, Leemiddelformer, Leemiddelstyrker, Administrasjonsmåte, Innehavere Av Markedsførinstillatelsen I Medlemslandene 1 Østerrike Belia Belia Bularia Kypros Kypros Pfizer Corporation Austria
More informationThe Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical
More informationEgy magyar, nagynyomású hidrogén-generátor Perspektívák és alkalmazások idehaza és külföldön
Egy magyar, nagynyomású hidrogén-generátor Perspektívák és alkalmazások idehaza és külföldön Dr. Darvas Ferenc Dr. Remzsı Tibor ThalesNano Zrt. (Budapest), ThalesNano LLC (Princeton, NJ, USA) Main Tech
More informationDecember 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage
More informationFunderingar om etik i medicinsk forskning. Hálfdán Pétursson PhD Forskare och ST-läkare
Funderingar om etik i medicinsk forskning Hálfdán Pétursson PhD Forskare och ST-läkare Etik i medicinsk forskning I. Ärlighet II. Mänskliga rättigheter och grundläggande medicinsk etik III. Metodik IV.Den
More informationSerialization Technology - Seidenader: Integral Solution Provider
Serialization Technology - Seidenader: Integral Solution Provider Sindusfarma August, 28th 2013 Dr. Stefan Loelkes Agenda 1 2 Your challenge Company overview 3 4 Integral solution provider Products 2 Your
More informationBlockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com
More informationLuxeMbOurG Trading CenTre LisT Annex 1 to the s pecial terms and conditions for securities transactions Valid as from 1 January 2011
Luxembourg Annex 1 to the Special terms and conditions for securities transactions Valid as from 1 January 2011 In order to achieve the best possible result in executing security orders, the bank has selected
More informationTrading in International Equities For Professional Advisers only - not to be relied upon by retail clients
Trading in International Equities For Professional Advisers only - not to be relied upon by retail clients 2 ALLIANCE TRUST SAVINGS About us We are part of the Alliance Trust group and have the backing
More informationThe Pharmaceutical Industry in Figures
The Pharmaceutical Industry in Figures Key Data 2013 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the researchbased pharmaceutical
More informationKey Findings. Use this report to... The Autoimmune Market Outlook to 2013
Key Findings The global autoimmune market generated sales of $31.9bn in, an increase of 14.4% over 2006 sales. The market is forecast to grow at a CAGR of 8.1% to reach a total value of $51.0bn in 2013.
More informationAnti-CD20 Monoclonal Antibodies - Global Strategic Business Report
Brochure More information from http://www.researchandmarkets.com/reports/1382330/ Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report Description: This report analyzes the Global market
More informationUniFlux 10: hollow fiber conversion kit (03-0089-67) installation instruction
GE Healthcare Instruction 28-9052-35 AA UniFlux 10: hollow fiber conversion kit (03-0089-67) installation instruction Important! Before commencing with the installation, carefully read through this document.
More informationChapter 5. Using bibliometrics to inform cancer research policy and spending
Chapter 5 Using bibliometrics to inform cancer research policy and spending Richard Sullivan, Seth Eckhouse and Grant Lewison for the European Cancer Research Managers Forum Richard Sullivan is chairman
More informationRx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency
Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency www.rx-360.org www.rx-360.org Presenter: Rob Welsh, VWR International, LLC VP Category Management
More informationStakeholder Insight: Insulin Use in Type 2 Diabetes
A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes
More informationChristopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration
Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration Clinical Research Center Learn-At-Lunch Series October 13, 2011
More informationFit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing
Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Thursday 08 October 2015 8-9 October 2015, Copenhagen (Denmark) Medicon Valley Alliance,
More informationBOLT Hem/Onc Thought Leader Panel #38 Cancer Immunotherapy 2014-05
Syndicated Thought Leader Insight Healthcare & Pharmaceutical Research Cancer Immunotherapy Melanoma, Non- Small Cell Lung Cancer, Renal Cell Carcinoma Thought Leader Panel #38 2014-05 Therapeutic Area:
More informationStakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice
A Datamonitor report Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice Published: Dec-06 Product Code: Providing you with: An overview of epidemiology,
More information全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report
/wepdwukltuyot 全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report 联 系 购 买 电 话 :010-82863480 公 司 名 称 : 佐 思 信 息 公 司 地 址 : 北 京 市 海 淀 区 苏 州 街 18 号 院 长 远 天
More informationGlobal Monoclonal Antibodies Pipeline Insight 2015
Brochure More information from http://www.researchandmarkets.com/reports/3113388/ Global Monoclonal Antibodies Pipeline Insight 2015 Description: Ever since the Nobel Prize was bestowed on the person who
More informationTop ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013
Brochure More information from http://www.researchandmarkets.com/reports/2599260/ Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Description: Synopsis This
More informationCORPORATE SPONSORSHIP OPPORTUNITIES 2012
LIFE SCIENCE ACADEMY CORPORATE SPONSORSHIP OPPORTUNITIES 2012 th Italian epharma day - Milan, April 19 German epharma day - Frankfurt, April 26 Spanish epharma day - Madrid, October 25 UK epharma day -
More informationPHARMACEUTICAL INDUSTRY PROFILE
PHARMACEUTICAL INDUSTRY PROFILE I. INDUSTRY BACKGROUND A. Industry Definition The U.S. pharmaceutical industry is defined by the Census Bureau as companies engaged in researching, developing, manufacturing,
More informationGlobal Top 100 Companies by market capitalisation
www.pwc.co.uk Companies by market capitalisation 31 March 2015 update An IPO Centre publication Contents Section 1 Highlights and trends 3 Section 2 Year-on-year comparison: 2015 vs. 2014 10 Section 3
More informationSeptember 23-25, 2002 - Hotel Fira Palace, Barcelona, Spain
5th Annual European Electronic Document Management Conference: Exploring Boundaries - Developing Solutions - Managing Globally Dedicated to Your Information & Advancement www.diahome.org September 23-25,
More informationMultiple Sclerosis Treatments: World Market Outlook to 2011
Brochure More information from http://www.researchandmarkets.com/reports/2860814/ Multiple Sclerosis Treatments: World Market Outlook to 2011 Description: Multiple sclerosis (MS) is a chronic demyelinating
More informationList of nationally authorised medicinal products
9 July 2015 EMA/483660/2015 Procedure Management and Committees Support Active substance: diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated), haemophilus type b conjugate
More informationLuxeMbOurG Trading CenT re LisT Annex 1 to the special terms and conditions for securities transactions Valid as from 1 september 2011
Luxembourg Annex 1 to the Special terms and conditions for securities transactions Valid as from 1 September 2011 In order to achieve the best possible result in executing security orders, the bank has
More informationClinical Trial Logistics
BOOK BY 31ST MARCH TO SAVE 100 SMi presents the 8th conference and exhibition series... Clinical Trial Logistics 21ST - 22ND MAY 2014 MARRIOTT REGENTS PARK LONDON, UK EUROPE'S LEADING CLINICAL TRIAL LOGISTICS
More informatione-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017
More informationMondelēz International entity which issued the PO matches Mondelēz International entity to which you issue your invoice
How to get your invoice paid on time? Truth is we want the same thing you do to process your invoices smoothly and pay on time. Reaching this goal requires contribution from all parties involved in ordering
More informationThe 2015 Avoca Report. Clinical Development Innovation. Sponsor and Provider Views on Innovation in Outsourced Clinical Development
The 2015 Avoca Report Clinical Development Innovation Sponsor and Provider Views on Innovation in Outsourced Clinical Development Contents Section Slides Research Overview 3-5 Respondent Demographics 6-9
More informationBrochure More information from http://www.researchandmarkets.com/reports/3292678/
Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long
More informationPharmaceutical industry
8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and
More informationMain Conference Agenda
Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental
More information3 Year: Year of the submission of the ingredient information.
1 2 Footnotes to Table 3 Name of Manufacturer or Importer: This information is submitted by Philip Morris Products S.A., which owns the relevant intellectual property rights of Philip Morris International
More informationMedical Communication Companies and Industry Grants
Research Brief Report Communication Companies and Industry Grants Sheila M. Rothman, PhD; Karen F. Brudney, MD; Whitney Adair, BA; David J. Rothman, PhD IMPORTANCE communication companies (MCCs) are among
More informationHow to get your invoice paid on time?
How to get your invoice paid on time? Truth is we want the same thing you do to process your invoices smoothly and pay on time. Moving to OB10 e-invoicing platform enhances our capabilities to reach this
More informationPr. Dominique JOLLY SKEMA BS. Animatrice : Valérie BLANCHOT COURTOIS
Cycle Innovation & Connaissance 17 petit déjeuner Vendredi 14 février 2014 Comment les entreprises occidentales parient sur la création technologique en Chine? Du cost-driven au knowledge-driven Pr. Dominique
More informationDublin, March 2013. EPSO Network of Experts in the field of Personnel Selection 14th March 2013
Dublin, March 2013 EPSO Network of Experts in the field of Personnel Selection 14th March 2013 On-going and upcoming competitions AD2012 by Citizenship AD2012 Citizenship %EU Population validated application
More informationERMInE Database. Presentation by Nils Flatabø SINTEF Energy Research. ERMInE Workshop 2 - Northern Europe Oslo, 1. November 2006
ERMInE Database Presentation by Nils Flatabø SINTEF Energy Research ERMInE Workshop 2 - Northern Europe Oslo, 1. November 26 Overview Content of the Ermine Database Electronic Questionnaire RTD&D Data
More informationRenewable Energy Certificate systems in Europe (the path to international trade)
Renewable Energy Certificate systems in Europe (the path to international trade) Marcel Galjee Board member RECS International Athens, March 31 st 2004 Outline of the presentation About RECS RECS International
More informationPipeline, timeline, deadline
Pipeline, timeline, deadline Improve your bottom line Life Sciences Building Management Solutions Put your buildings to work for you Keep your product pipeline flowing We ll show you how You re up against
More informationScott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry
Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry A Glance at the Pharmaceutical Industry The pharmaceutical industry is
More informationINCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
More informationProject Portfolio. Management. Our Expert. Pre-Conference Workshop 22 nd October 2014. Speaker Panel. 23 24 October 2014 Eurostars Berlin Hotel
visit our website: www.flemingeurope.com Our Expert Speaker Panel Martine Mazzetti AstraZeneca Vice President IMED Project Management Andreas Kirberg STADA Arzneimittel AG Vice President Business Development
More informationINTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS
INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS I. INTRODUCTION The International Pharmaceutical Privacy Consortium (IPPC)
More informationThe European Guide to Data Law
The European Guide to Data Law European Data Law 1.0 Introduction & Definitions 1.1 Introduction Recent legislation in the European Parliament related to data protection and privacy, and its various implementations
More informationExcellence in Oncology Clinical Trials
Oncology Clinical Trials We work to find a better way. We work to raise standards and deliver more. We break new ground to make progress possible. Oncology Research ICON is a global provider of outsourced
More informationH. Ammerlaan + 31 (0)79 345 8274
Informal document No. 16 (126th WP.29, 12-15 March 2002, agenda item 4.1.) UN ECE Transportdivision Secretariat - Mr. J. Jerie Palais des Nations 1211 Geneva 10 Zwitserland Transmitted by the representative
More informationsupplement 18 PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 1VIAL
supplement 18 NOM DOSAGE FORME NR ST LABORATOIRE PAYS D'ORIGINE ACTEMRA 80MG/4ML 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 218156/09 * CHUGAI PHARMA MANUFACTURING CO LTD FOR F.HOFFMANN-LA ROCHE LTD -
More informationGlobal Multiple Sclerosis Drugs Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/2925806/ Global Multiple Sclerosis Drugs Market 2014-2018 Description: About Multiple Sclerosis and Disease Types Multiple sclerosis
More informationour service / Expertise Global Reach Financial Security Bespoke Approach Claims Management
our service / Expertise AXA ART is a global insurance company that specialises in insuring the assets of private individuals, corporate collections, commercial art dealers, museums and exhibitions. Over
More informationCommercial Perspectives: Multiple Sclerosis
A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading
More informationEBiSC the first European bank for induced pluripotent stem cells
Press Release EBiSC the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA)
More informationHow To Buy Eclipse Premium
Eclipse Premium HOMOGENEOUS FLOORCOVERING VINYL > Harmonised colour range > Classic non-directional design > PUR reinforced Easy low-cost maintenance > Favourable initial cost > No additional surface treatment
More information